Effect of Fish Oil on Oxidative Stress, Lipid Profile and Renal Function in IgA Nephropathy

Journal of the Medical Association of Thailand

Volumn 87, Issue 2, 2004, Pages 143-149

  Parinyasiri, Uraiwan ^a   Parichatikanond, Paisal ^a   Liammongkolkul, Sompong ^a   Ong Sjyooth, Leena ^a   Ong Ajyooth, Sompong ^a   Kanyog, Surin ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Fish Oil; IgA Nephropathy; Oxidative Stress

Indexed keywords

ACETYLGLUCOSAMINIDASE; BETA 2 MICROGLOBULIN; CHOLESTEROL; CREATININE; DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN A; INTERLEUKIN 1; LEUKOTRIENE B5; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OMEGA 3 FATTY ACID; OXYGEN RADICAL; THROMBOXANE; THROMBOXANE A3; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIETARY INTAKE; DRUG CAPSULE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ENZYMURIA; EVALUATION; FEMALE; FOLLOW UP; FOOD COMPOSITION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN AGGREGATE; INFLAMMATION; KIDNEY BIOPSY; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MALE; NEUTROPHIL; OUTCOMES RESEARCH; OXIDATIVE STRESS; PROTEINURIA; SHORT COURSE THERAPY; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; TUBULAR DYSFUNCTION;

ADULT; ANALYSIS OF VARIANCE; CHOLESTEROL; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; FEMALE; FISH OILS; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1842811829     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Berger J, Hinglais N. Les depots intracapillaires d'IgA-IgG. J Urol Nephrol 1968; 74: 694-5.
2. Donadio JV Jr, Grande JP. Immunoglobulin A nephropathy: A clinical perspective. J Am Soc Nephrol 1997; 8: 1324-32.
3. Galla JH. Perspectives in clinical nephrology. IgA nephropathy. Kidney Int 1995; 47: 377-87.
4. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 1988; 84: 129-32.
5. Cattran DC. Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994; 23: 247-54.
6. Scheinman JI, Trachtman H, Lin CY, Langman CB, Chan JC. IgA nephropathy: to treat or not to treat? Nephron 1997; 75: 251-8.
7. Hamazaki T, Tateno S, Shishido H. Eicosapentaenoic. acid and IgA nephropathy. Lancet 1984; 1: 1017-8.
8. Kashem A, Endoh M, Yamauchi F, et al. Superoxide dismutase activity in human glomerulonephritis. Am J Kidney Dis 1996; 28: 14-22.
9. Futenma A, Yamada H, Kato K, Taki K. Distribution of glutathione peroxidase in the glomeruli of IgA nephropathy. Rinsho Byori 1994; 42: 1171-81.
10. Arao F, Yamada H, Katsumi K. Cu, Zn-superoxidase dismutase, glutathione peroxidase location in kidney of IgA nephropathy. Nippon Jinzo Gakkai Shi 1992; 34: 1047-53.
11. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: The Indian experiment of infarct survival-4. Cardiovasc Drugs Ther 1997; 11: 485-91.
12. 2-Microglobulin in urine and serum determined by ELISA technique. Scand J Clin Invest 1985; 45: 367-71.
13. Moor JC, Moris JE. A simple automated colorimetric method for determination of N-acetyl-β-D-glucosamonidase. Ann Clin Biochem 1982; 19: 157-9.
14. Knight JA, Smith SE, Kinder VE, Pier RK. Urinary lipoperoxides quantified by liquid chromatography and determination of reference values for adults. Clin Chem 1988; 34: 1107-10.
15. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 1994; 331: 1194-9.
16. Bennett WM, Walker RG, Kincaid-Smith P. Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two-year prospective trial. Clin Nephrol 1989; 31: 128-31.
17. Cheng IK, Chan PC, Chan MK. The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis. Nephrol Dial Transplant 1990; 5: 241-6.
18. Pettersson EE, Rekola S, Berglund L, et al. Treatment of IgA nephropathy with w-3-polyunsaturated fatty acids: A prospective, double-blind, randomized study, Clin Nephrol 1994; 41: 183-90.
19. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review. J Lipid Res 1989; 30: 785-807.
20. Illingworth DR, Connor WE, Hatcher LF, Harris WS. Hypolipidaemic effects of omega-3 fatty acids in primary hyperlipoproteinaemia. J Intern Med Suppl 1989; 225: 91-7.
21. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985; 312: 1210-6.
22. Syrjänen J, Mustonen J, Pasternack A. Hypertrigly-ceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000; 15: 34-42.
23. Samuelsson O, Mulec H, Knight-Gibson C, et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 1997; 12: 1908-15.
24. Samuelsson O, Aurell M, Knight-Gibson C, Alaupovic P, Attman PO. Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 1993; 63: 279-85.
25. Chen A, Chen WP, Sheu LF, Lin CY. Pathogenesis of IgA-nephropathy: In vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol 1994; 173: 119-26.
26. Pei Y, Scholey J, Thai K, Suzuki M, Cattran D. Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in Caucasian patients. J Clin Invest 1997; 100: 814-20.
27. Yi ZW, Rodriguez GE, Krieg RJ Jr, Tokieda K, Chan JC. Rat macrophages in experimental IgA nephropathy. Biochem Mol Med 1996; 57: 152-5.
28. αR expression on polymorphonuclear leukocyte and superoxide generation in IgA nephropathy. Kidney Int 1994; 45: 868-75.
29. Grande JP, Donadio JV Jr. Dietary fish oil supplementation in IgA nephropathy: A therapy in search of a mechanism. [Editorial] Nutrition 1998; 2: 240-2.
30. Schmitz PG, Zhang K, Dalal R. Eicosapentaenoic acid suppresses PDGF-induced DNA synthesis in rat mesangial cells: Involvement of thromboxane A2. Kidney Int 2000; 57: 1041-51.